nodes	percent_of_prediction	percent_of_DWPC	metapath
Nifedipine—CYP1A1—Clobetasol propionate—psoriasis	0.0585	0.0856	CbGbCtD
Nifedipine—CYP2A6—Methoxsalen—psoriasis	0.036	0.0526	CbGbCtD
Nifedipine—ABCC3—Cyclosporine—psoriasis	0.0353	0.0516	CbGbCtD
Nifedipine—CYP1A1—Methoxsalen—psoriasis	0.0307	0.045	CbGbCtD
Nifedipine—CYP2C8—Tazarotene—psoriasis	0.0275	0.0403	CbGbCtD
Nifedipine—CYP3A5—Beclomethasone—psoriasis	0.0266	0.0389	CbGbCtD
Nifedipine—CYP1A2—Clobetasol propionate—psoriasis	0.0261	0.0382	CbGbCtD
Nifedipine—ABCC2—Mycophenolate mofetil—psoriasis	0.0212	0.0309	CbGbCtD
Nifedipine—CYP1A1—Cholecalciferol—psoriasis	0.0204	0.0298	CbGbCtD
Nifedipine—ABCC3—Methotrexate—psoriasis	0.0187	0.0273	CbGbCtD
Nifedipine—CYP2A6—Prednisolone—psoriasis	0.0175	0.0256	CbGbCtD
Nifedipine—ABCC2—Cyclosporine—psoriasis	0.016	0.0235	CbGbCtD
Nifedipine—CYP2B6—Cholecalciferol—psoriasis	0.0155	0.0227	CbGbCtD
Nifedipine—CACNA1S—pes—psoriasis	0.0149	0.591	CbGeAlD
Nifedipine—CYP1A2—Methoxsalen—psoriasis	0.0137	0.0201	CbGbCtD
Nifedipine—CYP2D6—Hydroxyurea—psoriasis	0.0124	0.0181	CbGbCtD
Nifedipine—CYP2C8—Cholecalciferol—psoriasis	0.0118	0.0172	CbGbCtD
Nifedipine—CYP3A7—Hydrocortisone—psoriasis	0.0113	0.0166	CbGbCtD
Nifedipine—CYP3A7-CYP3A51P—Hydrocortisone—psoriasis	0.0113	0.0166	CbGbCtD
Nifedipine—CYP3A7—Cyclosporine—psoriasis	0.0107	0.0157	CbGbCtD
Nifedipine—CYP3A7-CYP3A51P—Cyclosporine—psoriasis	0.0107	0.0157	CbGbCtD
Nifedipine—CYP3A5—Mycophenolate mofetil—psoriasis	0.0106	0.0155	CbGbCtD
Nifedipine—ABCC2—Dexamethasone—psoriasis	0.0106	0.0154	CbGbCtD
Nifedipine—CYP2A6—Dexamethasone—psoriasis	0.0103	0.0151	CbGbCtD
Nifedipine—CYP2C8—Mycophenolate mofetil—psoriasis	0.0102	0.0149	CbGbCtD
Nifedipine—CYP3A4—Calcitriol—psoriasis	0.00925	0.0135	CbGbCtD
Nifedipine—CYP1A1—Dexamethasone—psoriasis	0.00881	0.0129	CbGbCtD
Nifedipine—CYP3A5—Hydrocortisone—psoriasis	0.00851	0.0124	CbGbCtD
Nifedipine—ABCC2—Methotrexate—psoriasis	0.00849	0.0124	CbGbCtD
Nifedipine—CYP2C9—Cholecalciferol—psoriasis	0.0082	0.012	CbGbCtD
Nifedipine—CYP2C8—Hydrocortisone—psoriasis	0.00818	0.012	CbGbCtD
Nifedipine—CYP3A5—Cyclosporine—psoriasis	0.00803	0.0117	CbGbCtD
Nifedipine—CYP2C8—Cyclosporine—psoriasis	0.00772	0.0113	CbGbCtD
Nifedipine—CYP2D6—Cholecalciferol—psoriasis	0.0075	0.011	CbGbCtD
Nifedipine—CYP3A4—Methoxsalen—psoriasis	0.0072	0.0105	CbGbCtD
Nifedipine—CYP3A7-CYP3A51P—Dexamethasone—psoriasis	0.00705	0.0103	CbGbCtD
Nifedipine—CYP3A7—Dexamethasone—psoriasis	0.00705	0.0103	CbGbCtD
Nifedipine—ABCB1—Mycophenolate mofetil—psoriasis	0.0069	0.0101	CbGbCtD
Nifedipine—CYP2E1—Dexamethasone—psoriasis	0.00681	0.00996	CbGbCtD
Nifedipine—CYP2B6—Dexamethasone—psoriasis	0.00671	0.00982	CbGbCtD
Nifedipine—ABCB1—Betamethasone—psoriasis	0.00592	0.00866	CbGbCtD
Nifedipine—ABCB1—Prednisolone—psoriasis	0.00584	0.00854	CbGbCtD
Nifedipine—ABCB1—Hydrocortisone—psoriasis	0.00554	0.0081	CbGbCtD
Nifedipine—ABCB1—Prednisone—psoriasis	0.00551	0.00807	CbGbCtD
Nifedipine—CYP2C9—Cyclosporine—psoriasis	0.00539	0.00788	CbGbCtD
Nifedipine—CYP3A5—Dexamethasone—psoriasis	0.00529	0.00774	CbGbCtD
Nifedipine—ABCB1—Cyclosporine—psoriasis	0.00523	0.00765	CbGbCtD
Nifedipine—CYP2C8—Dexamethasone—psoriasis	0.00509	0.00744	CbGbCtD
Nifedipine—CYP2D6—Cyclosporine—psoriasis	0.00493	0.0072	CbGbCtD
Nifedipine—CYP3A4—Cholecalciferol—psoriasis	0.00477	0.00697	CbGbCtD
Nifedipine—CYP3A4—Triamcinolone—psoriasis	0.00413	0.00604	CbGbCtD
Nifedipine—CYP3A4—Mycophenolate mofetil—psoriasis	0.00413	0.00604	CbGbCtD
Nifedipine—CYP2C9—Dexamethasone—psoriasis	0.00355	0.00519	CbGbCtD
Nifedipine—CYP3A4—Betamethasone—psoriasis	0.00355	0.00519	CbGbCtD
Nifedipine—CYP3A4—Prednisolone—psoriasis	0.0035	0.00512	CbGbCtD
Nifedipine—ABCB1—Dexamethasone—psoriasis	0.00344	0.00503	CbGbCtD
Nifedipine—CYP3A4—Hydrocortisone—psoriasis	0.00332	0.00485	CbGbCtD
Nifedipine—CYP3A4—Prednisone—psoriasis	0.0033	0.00483	CbGbCtD
Nifedipine—CYP2D6—Dexamethasone—psoriasis	0.00324	0.00474	CbGbCtD
Nifedipine—CYP3A4—Cyclosporine—psoriasis	0.00313	0.00458	CbGbCtD
Nifedipine—ABCB1—Methotrexate—psoriasis	0.00277	0.00405	CbGbCtD
Nifedipine—CYP3A4—Dexamethasone—psoriasis	0.00206	0.00302	CbGbCtD
Nifedipine—CYP1A1—skin epidermis—psoriasis	0.00118	0.0469	CbGeAlD
Nifedipine—CACNA1S—tendon—psoriasis	0.00114	0.0453	CbGeAlD
Nifedipine—CALM2—endothelium—psoriasis	0.00112	0.0444	CbGeAlD
Nifedipine—CALM1—endothelium—psoriasis	0.00112	0.0442	CbGeAlD
Nifedipine—KCNA1—tendon—psoriasis	0.000898	0.0356	CbGeAlD
Nifedipine—CACNB2—tendon—psoriasis	0.000686	0.0272	CbGeAlD
Nifedipine—CACNA2D1—tendon—psoriasis	0.000644	0.0256	CbGeAlD
Nifedipine—CALM2—skin of body—psoriasis	0.000478	0.019	CbGeAlD
Nifedipine—CALM1—skin of body—psoriasis	0.000476	0.0189	CbGeAlD
Nifedipine—CALM3—tendon—psoriasis	0.000464	0.0184	CbGeAlD
Nifedipine—ABCC2—tendon—psoriasis	0.000402	0.016	CbGeAlD
Nifedipine—CYP1A1—skin of body—psoriasis	0.000366	0.0145	CbGeAlD
Nifedipine—CALM2—tendon—psoriasis	0.000364	0.0144	CbGeAlD
Nifedipine—CALM1—tendon—psoriasis	0.000362	0.0144	CbGeAlD
Nifedipine—CYP2B6—skin of body—psoriasis	0.000356	0.0141	CbGeAlD
Nifedipine—CYP2E1—tendon—psoriasis	0.000254	0.0101	CbGeAlD
Nifedipine—Vomiting—Mycophenolic acid—psoriasis	6e-05	0.000273	CcSEcCtD
Nifedipine—Discomfort—Dexamethasone—psoriasis	5.97e-05	0.000272	CcSEcCtD
Nifedipine—Discomfort—Betamethasone—psoriasis	5.97e-05	0.000272	CcSEcCtD
Nifedipine—Dyspepsia—Hydrocortisone—psoriasis	5.97e-05	0.000272	CcSEcCtD
Nifedipine—Haemoglobin—Methotrexate—psoriasis	5.96e-05	0.000272	CcSEcCtD
Nifedipine—Rash—Mycophenolic acid—psoriasis	5.95e-05	0.000271	CcSEcCtD
Nifedipine—Dermatitis—Mycophenolic acid—psoriasis	5.94e-05	0.000271	CcSEcCtD
Nifedipine—Pain—Prednisolone—psoriasis	5.94e-05	0.000271	CcSEcCtD
Nifedipine—Haemorrhage—Methotrexate—psoriasis	5.93e-05	0.000271	CcSEcCtD
Nifedipine—Hepatitis—Methotrexate—psoriasis	5.93e-05	0.000271	CcSEcCtD
Nifedipine—Urticaria—Mycophenolate mofetil—psoriasis	5.91e-05	0.00027	CcSEcCtD
Nifedipine—Headache—Mycophenolic acid—psoriasis	5.91e-05	0.000269	CcSEcCtD
Nifedipine—Decreased appetite—Hydrocortisone—psoriasis	5.89e-05	0.000269	CcSEcCtD
Nifedipine—Pharyngitis—Methotrexate—psoriasis	5.89e-05	0.000269	CcSEcCtD
Nifedipine—Abdominal pain—Mycophenolate mofetil—psoriasis	5.88e-05	0.000268	CcSEcCtD
Nifedipine—Body temperature increased—Mycophenolate mofetil—psoriasis	5.88e-05	0.000268	CcSEcCtD
Nifedipine—Urinary tract disorder—Methotrexate—psoriasis	5.86e-05	0.000267	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Hydrocortisone—psoriasis	5.85e-05	0.000267	CcSEcCtD
Nifedipine—Fatigue—Hydrocortisone—psoriasis	5.85e-05	0.000267	CcSEcCtD
Nifedipine—Vision blurred—Prednisone—psoriasis	5.83e-05	0.000266	CcSEcCtD
Nifedipine—Urethral disorder—Methotrexate—psoriasis	5.82e-05	0.000265	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Triamcinolone—psoriasis	5.82e-05	0.000265	CcSEcCtD
Nifedipine—Pain—Hydrocortisone—psoriasis	5.8e-05	0.000264	CcSEcCtD
Nifedipine—Anaphylactic shock—Dexamethasone—psoriasis	5.79e-05	0.000264	CcSEcCtD
Nifedipine—Oedema—Betamethasone—psoriasis	5.79e-05	0.000264	CcSEcCtD
Nifedipine—Oedema—Dexamethasone—psoriasis	5.79e-05	0.000264	CcSEcCtD
Nifedipine—Anaphylactic shock—Betamethasone—psoriasis	5.79e-05	0.000264	CcSEcCtD
Nifedipine—Insomnia—Triamcinolone—psoriasis	5.77e-05	0.000263	CcSEcCtD
Nifedipine—Ill-defined disorder—Prednisone—psoriasis	5.74e-05	0.000262	CcSEcCtD
Nifedipine—Paraesthesia—Triamcinolone—psoriasis	5.73e-05	0.000261	CcSEcCtD
Nifedipine—Feeling abnormal—Prednisolone—psoriasis	5.72e-05	0.000261	CcSEcCtD
Nifedipine—Visual impairment—Methotrexate—psoriasis	5.72e-05	0.000261	CcSEcCtD
Nifedipine—Anaemia—Prednisone—psoriasis	5.71e-05	0.000261	CcSEcCtD
Nifedipine—Shock—Betamethasone—psoriasis	5.7e-05	0.00026	CcSEcCtD
Nifedipine—Shock—Dexamethasone—psoriasis	5.7e-05	0.00026	CcSEcCtD
Nifedipine—Dyspnoea—Triamcinolone—psoriasis	5.69e-05	0.00026	CcSEcCtD
Nifedipine—Nervous system disorder—Betamethasone—psoriasis	5.68e-05	0.000259	CcSEcCtD
Nifedipine—Nervous system disorder—Dexamethasone—psoriasis	5.68e-05	0.000259	CcSEcCtD
Nifedipine—Agitation—Prednisone—psoriasis	5.68e-05	0.000259	CcSEcCtD
Nifedipine—Thrombocytopenia—Betamethasone—psoriasis	5.67e-05	0.000259	CcSEcCtD
Nifedipine—Thrombocytopenia—Dexamethasone—psoriasis	5.67e-05	0.000259	CcSEcCtD
Nifedipine—Tachycardia—Betamethasone—psoriasis	5.65e-05	0.000258	CcSEcCtD
Nifedipine—Tachycardia—Dexamethasone—psoriasis	5.65e-05	0.000258	CcSEcCtD
Nifedipine—Angioedema—Prednisone—psoriasis	5.65e-05	0.000258	CcSEcCtD
Nifedipine—Hypersensitivity—Cyclosporine—psoriasis	5.62e-05	0.000256	CcSEcCtD
Nifedipine—Dyspepsia—Triamcinolone—psoriasis	5.62e-05	0.000256	CcSEcCtD
Nifedipine—Erythema multiforme—Methotrexate—psoriasis	5.61e-05	0.000256	CcSEcCtD
Nifedipine—Nausea—Mycophenolic acid—psoriasis	5.6e-05	0.000255	CcSEcCtD
Nifedipine—Hyperhidrosis—Dexamethasone—psoriasis	5.6e-05	0.000255	CcSEcCtD
Nifedipine—Hyperhidrosis—Betamethasone—psoriasis	5.6e-05	0.000255	CcSEcCtD
Nifedipine—Feeling abnormal—Hydrocortisone—psoriasis	5.59e-05	0.000255	CcSEcCtD
Nifedipine—Malaise—Prednisone—psoriasis	5.57e-05	0.000254	CcSEcCtD
Nifedipine—Vertigo—Prednisone—psoriasis	5.55e-05	0.000253	CcSEcCtD
Nifedipine—Eye disorder—Methotrexate—psoriasis	5.55e-05	0.000253	CcSEcCtD
Nifedipine—Gastrointestinal pain—Hydrocortisone—psoriasis	5.54e-05	0.000253	CcSEcCtD
Nifedipine—Syncope—Prednisone—psoriasis	5.54e-05	0.000253	CcSEcCtD
Nifedipine—Tinnitus—Methotrexate—psoriasis	5.53e-05	0.000252	CcSEcCtD
Nifedipine—Anorexia—Betamethasone—psoriasis	5.52e-05	0.000252	CcSEcCtD
Nifedipine—Anorexia—Dexamethasone—psoriasis	5.52e-05	0.000252	CcSEcCtD
Nifedipine—Urticaria—Prednisolone—psoriasis	5.52e-05	0.000252	CcSEcCtD
Nifedipine—Cardiac disorder—Methotrexate—psoriasis	5.51e-05	0.000251	CcSEcCtD
Nifedipine—Fatigue—Triamcinolone—psoriasis	5.5e-05	0.000251	CcSEcCtD
Nifedipine—Hypersensitivity—Mycophenolate mofetil—psoriasis	5.48e-05	0.00025	CcSEcCtD
Nifedipine—Asthenia—Cyclosporine—psoriasis	5.47e-05	0.00025	CcSEcCtD
Nifedipine—Pain—Triamcinolone—psoriasis	5.46e-05	0.000249	CcSEcCtD
Nifedipine—Loss of consciousness—Prednisone—psoriasis	5.43e-05	0.000248	CcSEcCtD
Nifedipine—Hypotension—Dexamethasone—psoriasis	5.41e-05	0.000247	CcSEcCtD
Nifedipine—Hypotension—Betamethasone—psoriasis	5.41e-05	0.000247	CcSEcCtD
Nifedipine—Pruritus—Cyclosporine—psoriasis	5.4e-05	0.000246	CcSEcCtD
Nifedipine—Urticaria—Hydrocortisone—psoriasis	5.39e-05	0.000246	CcSEcCtD
Nifedipine—Angiopathy—Methotrexate—psoriasis	5.38e-05	0.000246	CcSEcCtD
Nifedipine—Immune system disorder—Methotrexate—psoriasis	5.36e-05	0.000244	CcSEcCtD
Nifedipine—Abdominal pain—Hydrocortisone—psoriasis	5.36e-05	0.000244	CcSEcCtD
Nifedipine—Body temperature increased—Hydrocortisone—psoriasis	5.36e-05	0.000244	CcSEcCtD
Nifedipine—Mediastinal disorder—Methotrexate—psoriasis	5.35e-05	0.000244	CcSEcCtD
Nifedipine—Asthenia—Mycophenolate mofetil—psoriasis	5.34e-05	0.000244	CcSEcCtD
Nifedipine—Chills—Methotrexate—psoriasis	5.32e-05	0.000243	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Betamethasone—psoriasis	5.28e-05	0.000241	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Dexamethasone—psoriasis	5.28e-05	0.000241	CcSEcCtD
Nifedipine—Pruritus—Mycophenolate mofetil—psoriasis	5.27e-05	0.00024	CcSEcCtD
Nifedipine—Myalgia—Prednisone—psoriasis	5.26e-05	0.00024	CcSEcCtD
Nifedipine—Arthralgia—Prednisone—psoriasis	5.26e-05	0.00024	CcSEcCtD
Nifedipine—Feeling abnormal—Triamcinolone—psoriasis	5.26e-05	0.00024	CcSEcCtD
Nifedipine—Anxiety—Prednisone—psoriasis	5.24e-05	0.000239	CcSEcCtD
Nifedipine—Alopecia—Methotrexate—psoriasis	5.24e-05	0.000239	CcSEcCtD
Nifedipine—Insomnia—Betamethasone—psoriasis	5.24e-05	0.000239	CcSEcCtD
Nifedipine—Insomnia—Dexamethasone—psoriasis	5.24e-05	0.000239	CcSEcCtD
Nifedipine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	5.23e-05	0.000238	CcSEcCtD
Nifedipine—Diarrhoea—Cyclosporine—psoriasis	5.22e-05	0.000238	CcSEcCtD
Nifedipine—Paraesthesia—Betamethasone—psoriasis	5.2e-05	0.000237	CcSEcCtD
Nifedipine—Paraesthesia—Dexamethasone—psoriasis	5.2e-05	0.000237	CcSEcCtD
Nifedipine—Discomfort—Prednisone—psoriasis	5.2e-05	0.000237	CcSEcCtD
Nifedipine—Mental disorder—Methotrexate—psoriasis	5.2e-05	0.000237	CcSEcCtD
Nifedipine—Erythema—Methotrexate—psoriasis	5.17e-05	0.000236	CcSEcCtD
Nifedipine—Malnutrition—Methotrexate—psoriasis	5.17e-05	0.000236	CcSEcCtD
Nifedipine—Hypersensitivity—Prednisolone—psoriasis	5.12e-05	0.000233	CcSEcCtD
Nifedipine—Dyspepsia—Betamethasone—psoriasis	5.1e-05	0.000233	CcSEcCtD
Nifedipine—Dyspepsia—Dexamethasone—psoriasis	5.1e-05	0.000233	CcSEcCtD
Nifedipine—Diarrhoea—Mycophenolate mofetil—psoriasis	5.09e-05	0.000232	CcSEcCtD
Nifedipine—Urticaria—Triamcinolone—psoriasis	5.07e-05	0.000231	CcSEcCtD
Nifedipine—Dysgeusia—Methotrexate—psoriasis	5.06e-05	0.000231	CcSEcCtD
Nifedipine—Body temperature increased—Triamcinolone—psoriasis	5.05e-05	0.00023	CcSEcCtD
Nifedipine—Dizziness—Cyclosporine—psoriasis	5.05e-05	0.00023	CcSEcCtD
Nifedipine—Oedema—Prednisone—psoriasis	5.04e-05	0.00023	CcSEcCtD
Nifedipine—Anaphylactic shock—Prednisone—psoriasis	5.04e-05	0.00023	CcSEcCtD
Nifedipine—Decreased appetite—Betamethasone—psoriasis	5.04e-05	0.00023	CcSEcCtD
Nifedipine—Decreased appetite—Dexamethasone—psoriasis	5.04e-05	0.00023	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Dexamethasone—psoriasis	5e-05	0.000228	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Betamethasone—psoriasis	5e-05	0.000228	CcSEcCtD
Nifedipine—Back pain—Methotrexate—psoriasis	5e-05	0.000228	CcSEcCtD
Nifedipine—Hypersensitivity—Hydrocortisone—psoriasis	5e-05	0.000228	CcSEcCtD
Nifedipine—Fatigue—Dexamethasone—psoriasis	4.99e-05	0.000228	CcSEcCtD
Nifedipine—Fatigue—Betamethasone—psoriasis	4.99e-05	0.000228	CcSEcCtD
Nifedipine—Shock—Prednisone—psoriasis	4.96e-05	0.000226	CcSEcCtD
Nifedipine—Pain—Betamethasone—psoriasis	4.95e-05	0.000226	CcSEcCtD
Nifedipine—Pain—Dexamethasone—psoriasis	4.95e-05	0.000226	CcSEcCtD
Nifedipine—Nervous system disorder—Prednisone—psoriasis	4.95e-05	0.000226	CcSEcCtD
Nifedipine—Tachycardia—Prednisone—psoriasis	4.92e-05	0.000225	CcSEcCtD
Nifedipine—Dizziness—Mycophenolate mofetil—psoriasis	4.92e-05	0.000224	CcSEcCtD
Nifedipine—Skin disorder—Prednisone—psoriasis	4.9e-05	0.000223	CcSEcCtD
Nifedipine—Hyperhidrosis—Prednisone—psoriasis	4.88e-05	0.000222	CcSEcCtD
Nifedipine—Vision blurred—Methotrexate—psoriasis	4.87e-05	0.000222	CcSEcCtD
Nifedipine—Asthenia—Hydrocortisone—psoriasis	4.86e-05	0.000222	CcSEcCtD
Nifedipine—Vomiting—Cyclosporine—psoriasis	4.85e-05	0.000221	CcSEcCtD
Nifedipine—Rash—Cyclosporine—psoriasis	4.81e-05	0.000219	CcSEcCtD
Nifedipine—Anorexia—Prednisone—psoriasis	4.81e-05	0.000219	CcSEcCtD
Nifedipine—Dermatitis—Cyclosporine—psoriasis	4.81e-05	0.000219	CcSEcCtD
Nifedipine—Pruritus—Hydrocortisone—psoriasis	4.8e-05	0.000219	CcSEcCtD
Nifedipine—Ill-defined disorder—Methotrexate—psoriasis	4.79e-05	0.000219	CcSEcCtD
Nifedipine—Headache—Cyclosporine—psoriasis	4.78e-05	0.000218	CcSEcCtD
Nifedipine—Anaemia—Methotrexate—psoriasis	4.77e-05	0.000218	CcSEcCtD
Nifedipine—Feeling abnormal—Dexamethasone—psoriasis	4.77e-05	0.000218	CcSEcCtD
Nifedipine—Feeling abnormal—Betamethasone—psoriasis	4.77e-05	0.000218	CcSEcCtD
Nifedipine—Gastrointestinal pain—Betamethasone—psoriasis	4.74e-05	0.000216	CcSEcCtD
Nifedipine—Gastrointestinal pain—Dexamethasone—psoriasis	4.74e-05	0.000216	CcSEcCtD
Nifedipine—Vomiting—Mycophenolate mofetil—psoriasis	4.73e-05	0.000216	CcSEcCtD
Nifedipine—Hypersensitivity—Triamcinolone—psoriasis	4.7e-05	0.000215	CcSEcCtD
Nifedipine—Rash—Mycophenolate mofetil—psoriasis	4.69e-05	0.000214	CcSEcCtD
Nifedipine—Dermatitis—Mycophenolate mofetil—psoriasis	4.69e-05	0.000214	CcSEcCtD
Nifedipine—Headache—Mycophenolate mofetil—psoriasis	4.66e-05	0.000213	CcSEcCtD
Nifedipine—Malaise—Methotrexate—psoriasis	4.66e-05	0.000212	CcSEcCtD
Nifedipine—Vertigo—Methotrexate—psoriasis	4.64e-05	0.000212	CcSEcCtD
Nifedipine—Diarrhoea—Hydrocortisone—psoriasis	4.64e-05	0.000212	CcSEcCtD
Nifedipine—Leukopenia—Methotrexate—psoriasis	4.62e-05	0.000211	CcSEcCtD
Nifedipine—Urticaria—Betamethasone—psoriasis	4.6e-05	0.00021	CcSEcCtD
Nifedipine—Urticaria—Dexamethasone—psoriasis	4.6e-05	0.00021	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Prednisone—psoriasis	4.6e-05	0.00021	CcSEcCtD
Nifedipine—Dizziness—Prednisolone—psoriasis	4.59e-05	0.000209	CcSEcCtD
Nifedipine—Asthenia—Triamcinolone—psoriasis	4.58e-05	0.000209	CcSEcCtD
Nifedipine—Abdominal pain—Betamethasone—psoriasis	4.58e-05	0.000209	CcSEcCtD
Nifedipine—Body temperature increased—Betamethasone—psoriasis	4.58e-05	0.000209	CcSEcCtD
Nifedipine—Body temperature increased—Dexamethasone—psoriasis	4.58e-05	0.000209	CcSEcCtD
Nifedipine—Abdominal pain—Dexamethasone—psoriasis	4.58e-05	0.000209	CcSEcCtD
Nifedipine—Insomnia—Prednisone—psoriasis	4.56e-05	0.000208	CcSEcCtD
Nifedipine—Nausea—Cyclosporine—psoriasis	4.53e-05	0.000207	CcSEcCtD
Nifedipine—Paraesthesia—Prednisone—psoriasis	4.53e-05	0.000207	CcSEcCtD
Nifedipine—Pruritus—Triamcinolone—psoriasis	4.52e-05	0.000206	CcSEcCtD
Nifedipine—Cough—Methotrexate—psoriasis	4.51e-05	0.000206	CcSEcCtD
Nifedipine—Dizziness—Hydrocortisone—psoriasis	4.48e-05	0.000204	CcSEcCtD
Nifedipine—Dyspepsia—Prednisone—psoriasis	4.44e-05	0.000203	CcSEcCtD
Nifedipine—Nausea—Mycophenolate mofetil—psoriasis	4.42e-05	0.000202	CcSEcCtD
Nifedipine—Arthralgia—Methotrexate—psoriasis	4.4e-05	0.000201	CcSEcCtD
Nifedipine—Chest pain—Methotrexate—psoriasis	4.4e-05	0.000201	CcSEcCtD
Nifedipine—Myalgia—Methotrexate—psoriasis	4.4e-05	0.000201	CcSEcCtD
Nifedipine—Decreased appetite—Prednisone—psoriasis	4.39e-05	0.0002	CcSEcCtD
Nifedipine—Rash—Prednisolone—psoriasis	4.38e-05	0.0002	CcSEcCtD
Nifedipine—Dermatitis—Prednisolone—psoriasis	4.37e-05	0.000199	CcSEcCtD
Nifedipine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	4.37e-05	0.000199	CcSEcCtD
Nifedipine—Fatigue—Prednisone—psoriasis	4.35e-05	0.000198	CcSEcCtD
Nifedipine—Headache—Prednisolone—psoriasis	4.35e-05	0.000198	CcSEcCtD
Nifedipine—Discomfort—Methotrexate—psoriasis	4.35e-05	0.000198	CcSEcCtD
Nifedipine—Constipation—Prednisone—psoriasis	4.31e-05	0.000197	CcSEcCtD
Nifedipine—Vomiting—Hydrocortisone—psoriasis	4.31e-05	0.000197	CcSEcCtD
Nifedipine—Rash—Hydrocortisone—psoriasis	4.28e-05	0.000195	CcSEcCtD
Nifedipine—Dermatitis—Hydrocortisone—psoriasis	4.27e-05	0.000195	CcSEcCtD
Nifedipine—Confusional state—Methotrexate—psoriasis	4.25e-05	0.000194	CcSEcCtD
Nifedipine—Headache—Hydrocortisone—psoriasis	4.25e-05	0.000194	CcSEcCtD
Nifedipine—Dizziness—Triamcinolone—psoriasis	4.22e-05	0.000193	CcSEcCtD
Nifedipine—Anaphylactic shock—Methotrexate—psoriasis	4.22e-05	0.000192	CcSEcCtD
Nifedipine—Feeling abnormal—Prednisone—psoriasis	4.16e-05	0.00019	CcSEcCtD
Nifedipine—Asthenia—Dexamethasone—psoriasis	4.16e-05	0.00019	CcSEcCtD
Nifedipine—Asthenia—Betamethasone—psoriasis	4.16e-05	0.00019	CcSEcCtD
Nifedipine—Nervous system disorder—Methotrexate—psoriasis	4.13e-05	0.000189	CcSEcCtD
Nifedipine—Thrombocytopenia—Methotrexate—psoriasis	4.13e-05	0.000188	CcSEcCtD
Nifedipine—Gastrointestinal pain—Prednisone—psoriasis	4.13e-05	0.000188	CcSEcCtD
Nifedipine—Nausea—Prednisolone—psoriasis	4.12e-05	0.000188	CcSEcCtD
Nifedipine—Pruritus—Betamethasone—psoriasis	4.1e-05	0.000187	CcSEcCtD
Nifedipine—Pruritus—Dexamethasone—psoriasis	4.1e-05	0.000187	CcSEcCtD
Nifedipine—Skin disorder—Methotrexate—psoriasis	4.1e-05	0.000187	CcSEcCtD
Nifedipine—Hyperhidrosis—Methotrexate—psoriasis	4.08e-05	0.000186	CcSEcCtD
Nifedipine—Vomiting—Triamcinolone—psoriasis	4.06e-05	0.000185	CcSEcCtD
Nifedipine—Nausea—Hydrocortisone—psoriasis	4.03e-05	0.000184	CcSEcCtD
Nifedipine—Rash—Triamcinolone—psoriasis	4.03e-05	0.000184	CcSEcCtD
Nifedipine—Dermatitis—Triamcinolone—psoriasis	4.02e-05	0.000183	CcSEcCtD
Nifedipine—Anorexia—Methotrexate—psoriasis	4.02e-05	0.000183	CcSEcCtD
Nifedipine—Urticaria—Prednisone—psoriasis	4.01e-05	0.000183	CcSEcCtD
Nifedipine—Headache—Triamcinolone—psoriasis	4e-05	0.000182	CcSEcCtD
Nifedipine—Abdominal pain—Prednisone—psoriasis	3.99e-05	0.000182	CcSEcCtD
Nifedipine—Body temperature increased—Prednisone—psoriasis	3.99e-05	0.000182	CcSEcCtD
Nifedipine—Diarrhoea—Betamethasone—psoriasis	3.96e-05	0.000181	CcSEcCtD
Nifedipine—Diarrhoea—Dexamethasone—psoriasis	3.96e-05	0.000181	CcSEcCtD
Nifedipine—Hypotension—Methotrexate—psoriasis	3.94e-05	0.00018	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Methotrexate—psoriasis	3.84e-05	0.000175	CcSEcCtD
Nifedipine—Dizziness—Dexamethasone—psoriasis	3.83e-05	0.000175	CcSEcCtD
Nifedipine—Dizziness—Betamethasone—psoriasis	3.83e-05	0.000175	CcSEcCtD
Nifedipine—Insomnia—Methotrexate—psoriasis	3.81e-05	0.000174	CcSEcCtD
Nifedipine—Nausea—Triamcinolone—psoriasis	3.79e-05	0.000173	CcSEcCtD
Nifedipine—Paraesthesia—Methotrexate—psoriasis	3.79e-05	0.000173	CcSEcCtD
Nifedipine—Dyspnoea—Methotrexate—psoriasis	3.76e-05	0.000171	CcSEcCtD
Nifedipine—Somnolence—Methotrexate—psoriasis	3.75e-05	0.000171	CcSEcCtD
Nifedipine—Hypersensitivity—Prednisone—psoriasis	3.72e-05	0.00017	CcSEcCtD
Nifedipine—Dyspepsia—Methotrexate—psoriasis	3.71e-05	0.000169	CcSEcCtD
Nifedipine—Vomiting—Betamethasone—psoriasis	3.68e-05	0.000168	CcSEcCtD
Nifedipine—Vomiting—Dexamethasone—psoriasis	3.68e-05	0.000168	CcSEcCtD
Nifedipine—Decreased appetite—Methotrexate—psoriasis	3.67e-05	0.000167	CcSEcCtD
Nifedipine—Rash—Betamethasone—psoriasis	3.65e-05	0.000167	CcSEcCtD
Nifedipine—Rash—Dexamethasone—psoriasis	3.65e-05	0.000167	CcSEcCtD
Nifedipine—Dermatitis—Betamethasone—psoriasis	3.65e-05	0.000166	CcSEcCtD
Nifedipine—Dermatitis—Dexamethasone—psoriasis	3.65e-05	0.000166	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Methotrexate—psoriasis	3.64e-05	0.000166	CcSEcCtD
Nifedipine—Fatigue—Methotrexate—psoriasis	3.64e-05	0.000166	CcSEcCtD
Nifedipine—Headache—Betamethasone—psoriasis	3.63e-05	0.000166	CcSEcCtD
Nifedipine—Headache—Dexamethasone—psoriasis	3.63e-05	0.000166	CcSEcCtD
Nifedipine—Asthenia—Prednisone—psoriasis	3.62e-05	0.000165	CcSEcCtD
Nifedipine—Pain—Methotrexate—psoriasis	3.61e-05	0.000164	CcSEcCtD
Nifedipine—Pruritus—Prednisone—psoriasis	3.57e-05	0.000163	CcSEcCtD
Nifedipine—Feeling abnormal—Methotrexate—psoriasis	3.47e-05	0.000158	CcSEcCtD
Nifedipine—Diarrhoea—Prednisone—psoriasis	3.45e-05	0.000157	CcSEcCtD
Nifedipine—Gastrointestinal pain—Methotrexate—psoriasis	3.45e-05	0.000157	CcSEcCtD
Nifedipine—Nausea—Dexamethasone—psoriasis	3.44e-05	0.000157	CcSEcCtD
Nifedipine—Nausea—Betamethasone—psoriasis	3.44e-05	0.000157	CcSEcCtD
Nifedipine—Urticaria—Methotrexate—psoriasis	3.35e-05	0.000153	CcSEcCtD
Nifedipine—Dizziness—Prednisone—psoriasis	3.34e-05	0.000152	CcSEcCtD
Nifedipine—Abdominal pain—Methotrexate—psoriasis	3.33e-05	0.000152	CcSEcCtD
Nifedipine—Body temperature increased—Methotrexate—psoriasis	3.33e-05	0.000152	CcSEcCtD
Nifedipine—Vomiting—Prednisone—psoriasis	3.21e-05	0.000146	CcSEcCtD
Nifedipine—Rash—Prednisone—psoriasis	3.18e-05	0.000145	CcSEcCtD
Nifedipine—Dermatitis—Prednisone—psoriasis	3.18e-05	0.000145	CcSEcCtD
Nifedipine—Headache—Prednisone—psoriasis	3.16e-05	0.000144	CcSEcCtD
Nifedipine—Hypersensitivity—Methotrexate—psoriasis	3.11e-05	0.000142	CcSEcCtD
Nifedipine—Asthenia—Methotrexate—psoriasis	3.03e-05	0.000138	CcSEcCtD
Nifedipine—Nausea—Prednisone—psoriasis	3e-05	0.000137	CcSEcCtD
Nifedipine—Pruritus—Methotrexate—psoriasis	2.98e-05	0.000136	CcSEcCtD
Nifedipine—Diarrhoea—Methotrexate—psoriasis	2.88e-05	0.000132	CcSEcCtD
Nifedipine—Dizziness—Methotrexate—psoriasis	2.79e-05	0.000127	CcSEcCtD
Nifedipine—Vomiting—Methotrexate—psoriasis	2.68e-05	0.000122	CcSEcCtD
Nifedipine—Rash—Methotrexate—psoriasis	2.66e-05	0.000121	CcSEcCtD
Nifedipine—Dermatitis—Methotrexate—psoriasis	2.66e-05	0.000121	CcSEcCtD
Nifedipine—Headache—Methotrexate—psoriasis	2.64e-05	0.00012	CcSEcCtD
Nifedipine—Nausea—Methotrexate—psoriasis	2.5e-05	0.000114	CcSEcCtD
Nifedipine—CALM3—Signaling by EGFR—IL6—psoriasis	1.35e-05	0.000188	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—CARM1—psoriasis	1.34e-05	0.000187	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—CARM1—psoriasis	1.34e-05	0.000186	CbGpPWpGaD
Nifedipine—CALM3—Immune System—HLA-E—psoriasis	1.34e-05	0.000186	CbGpPWpGaD
Nifedipine—CALM3—Signaling by EGFR in Cancer—IL6—psoriasis	1.33e-05	0.000186	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—CARM1—psoriasis	1.33e-05	0.000186	CbGpPWpGaD
Nifedipine—CALM3—Adaptive Immune System—HLA-DRB1—psoriasis	1.33e-05	0.000185	CbGpPWpGaD
Nifedipine—CALM3—Signaling by PDGF—IL6—psoriasis	1.33e-05	0.000185	CbGpPWpGaD
Nifedipine—CALM3—Signaling by NGF—STAT3—psoriasis	1.32e-05	0.000185	CbGpPWpGaD
Nifedipine—CALM3—Innate Immune System—NFKBIA—psoriasis	1.32e-05	0.000184	CbGpPWpGaD
Nifedipine—CALM1—Signaling by FGFR in disease—IL6—psoriasis	1.31e-05	0.000183	CbGpPWpGaD
Nifedipine—CALM1—DAP12 interactions—IL6—psoriasis	1.31e-05	0.000183	CbGpPWpGaD
Nifedipine—CALM2—Fc epsilon receptor (FCERI) signaling—IL6—psoriasis	1.31e-05	0.000183	CbGpPWpGaD
Nifedipine—CALM1—Fc epsilon receptor (FCERI) signaling—IL6—psoriasis	1.31e-05	0.000183	CbGpPWpGaD
Nifedipine—CALM2—DAP12 interactions—IL6—psoriasis	1.31e-05	0.000183	CbGpPWpGaD
Nifedipine—CALM2—Signaling by FGFR in disease—IL6—psoriasis	1.31e-05	0.000183	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CCL20—psoriasis	1.31e-05	0.000183	CbGpPWpGaD
Nifedipine—CALM2—Signaling by EGFR—IL6—psoriasis	1.3e-05	0.000181	CbGpPWpGaD
Nifedipine—CALM1—Signaling by EGFR—IL6—psoriasis	1.3e-05	0.000181	CbGpPWpGaD
Nifedipine—ABCC3—Metabolism—APOE—psoriasis	1.29e-05	0.00018	CbGpPWpGaD
Nifedipine—CALM2—Immune System—HLA-E—psoriasis	1.29e-05	0.00018	CbGpPWpGaD
Nifedipine—CALM1—Immune System—HLA-E—psoriasis	1.29e-05	0.00018	CbGpPWpGaD
Nifedipine—CALM1—Signaling by EGFR in Cancer—IL6—psoriasis	1.29e-05	0.00018	CbGpPWpGaD
Nifedipine—CALM2—Signaling by EGFR in Cancer—IL6—psoriasis	1.29e-05	0.00018	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—CARM1—psoriasis	1.29e-05	0.00018	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—CARM1—psoriasis	1.29e-05	0.00018	CbGpPWpGaD
Nifedipine—CALM2—Adaptive Immune System—HLA-DRB1—psoriasis	1.29e-05	0.000179	CbGpPWpGaD
Nifedipine—CALM1—Adaptive Immune System—HLA-DRB1—psoriasis	1.29e-05	0.000179	CbGpPWpGaD
Nifedipine—CALM2—Signaling by PDGF—IL6—psoriasis	1.29e-05	0.000179	CbGpPWpGaD
Nifedipine—CALM1—Signaling by PDGF—IL6—psoriasis	1.29e-05	0.000179	CbGpPWpGaD
Nifedipine—CALM2—Signaling by NGF—STAT3—psoriasis	1.28e-05	0.000179	CbGpPWpGaD
Nifedipine—CALM1—Signaling by NGF—STAT3—psoriasis	1.28e-05	0.000179	CbGpPWpGaD
Nifedipine—CALM3—Adaptive Immune System—ICAM1—psoriasis	1.28e-05	0.000178	CbGpPWpGaD
Nifedipine—CALM2—Innate Immune System—NFKBIA—psoriasis	1.27e-05	0.000178	CbGpPWpGaD
Nifedipine—CALM1—Innate Immune System—NFKBIA—psoriasis	1.27e-05	0.000178	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—CYP2S1—psoriasis	1.27e-05	0.000178	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CCL20—psoriasis	1.27e-05	0.000177	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CCL20—psoriasis	1.27e-05	0.000177	CbGpPWpGaD
Nifedipine—CALM3—Adaptive Immune System—NFKBIA—psoriasis	1.27e-05	0.000176	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—CARM1—psoriasis	1.26e-05	0.000176	CbGpPWpGaD
Nifedipine—CACNA1C—Metabolism—PPARG—psoriasis	1.26e-05	0.000175	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.24e-05	0.000173	CbGpPWpGaD
Nifedipine—CALM1—Adaptive Immune System—ICAM1—psoriasis	1.23e-05	0.000172	CbGpPWpGaD
Nifedipine—CALM2—Adaptive Immune System—ICAM1—psoriasis	1.23e-05	0.000172	CbGpPWpGaD
Nifedipine—CALM2—Adaptive Immune System—NFKBIA—psoriasis	1.22e-05	0.000171	CbGpPWpGaD
Nifedipine—CALM1—Adaptive Immune System—NFKBIA—psoriasis	1.22e-05	0.000171	CbGpPWpGaD
Nifedipine—CALM3—NGF signalling via TRKA from the plasma membrane—IL6—psoriasis	1.2e-05	0.000168	CbGpPWpGaD
Nifedipine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.2e-05	0.000167	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.18e-05	0.000165	CbGpPWpGaD
Nifedipine—CALM1—NGF signalling via TRKA from the plasma membrane—IL6—psoriasis	1.16e-05	0.000162	CbGpPWpGaD
Nifedipine—CALM2—NGF signalling via TRKA from the plasma membrane—IL6—psoriasis	1.16e-05	0.000162	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—CARM1—psoriasis	1.16e-05	0.000162	CbGpPWpGaD
Nifedipine—CYP3A7—Metabolism—CAT—psoriasis	1.14e-05	0.000159	CbGpPWpGaD
Nifedipine—ABCC3—Metabolism—PPARG—psoriasis	1.13e-05	0.000157	CbGpPWpGaD
Nifedipine—CALM3—Immune System—SOCS1—psoriasis	1.12e-05	0.000156	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.08e-05	0.000151	CbGpPWpGaD
Nifedipine—CALM2—Immune System—SOCS1—psoriasis	1.08e-05	0.00015	CbGpPWpGaD
Nifedipine—CALM1—Immune System—SOCS1—psoriasis	1.08e-05	0.00015	CbGpPWpGaD
Nifedipine—CALM3—Innate Immune System—TYK2—psoriasis	1.08e-05	0.00015	CbGpPWpGaD
Nifedipine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	1.06e-05	0.000147	CbGpPWpGaD
Nifedipine—CALM1—Innate Immune System—TYK2—psoriasis	1.04e-05	0.000145	CbGpPWpGaD
Nifedipine—CALM2—Innate Immune System—TYK2—psoriasis	1.04e-05	0.000145	CbGpPWpGaD
Nifedipine—CYP2A6—Metabolism—CAT—psoriasis	1.04e-05	0.000145	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.01e-05	0.000141	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—CARM1—psoriasis	1.01e-05	0.000141	CbGpPWpGaD
Nifedipine—CALM3—Immune System—CD8A—psoriasis	9.9e-06	0.000138	CbGpPWpGaD
Nifedipine—CALM3—Innate Immune System—CD4—psoriasis	9.76e-06	0.000136	CbGpPWpGaD
Nifedipine—CALM2—Immune System—CD8A—psoriasis	9.57e-06	0.000133	CbGpPWpGaD
Nifedipine—CALM1—Immune System—CD8A—psoriasis	9.57e-06	0.000133	CbGpPWpGaD
Nifedipine—CALM3—Immune System—HLA-B—psoriasis	9.52e-06	0.000133	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—CARM1—psoriasis	9.51e-06	0.000133	CbGpPWpGaD
Nifedipine—CALM2—Innate Immune System—CD4—psoriasis	9.44e-06	0.000132	CbGpPWpGaD
Nifedipine—CALM1—Innate Immune System—CD4—psoriasis	9.44e-06	0.000132	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—CARM1—psoriasis	9.43e-06	0.000131	CbGpPWpGaD
Nifedipine—CALM3—Adaptive Immune System—CD4—psoriasis	9.37e-06	0.000131	CbGpPWpGaD
Nifedipine—CALM3—Signaling by NGF—IL6—psoriasis	9.25e-06	0.000129	CbGpPWpGaD
Nifedipine—CALM1—Immune System—HLA-B—psoriasis	9.21e-06	0.000128	CbGpPWpGaD
Nifedipine—CALM2—Immune System—HLA-B—psoriasis	9.21e-06	0.000128	CbGpPWpGaD
Nifedipine—CALM1—Adaptive Immune System—CD4—psoriasis	9.07e-06	0.000126	CbGpPWpGaD
Nifedipine—CALM2—Adaptive Immune System—CD4—psoriasis	9.07e-06	0.000126	CbGpPWpGaD
Nifedipine—CALM2—Signaling by NGF—IL6—psoriasis	8.95e-06	0.000125	CbGpPWpGaD
Nifedipine—CALM1—Signaling by NGF—IL6—psoriasis	8.95e-06	0.000125	CbGpPWpGaD
Nifedipine—CYP3A7—Metabolism—APOE—psoriasis	8.85e-06	0.000123	CbGpPWpGaD
Nifedipine—CALM3—Immune System—HLA-A—psoriasis	8.82e-06	0.000123	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	8.82e-06	0.000123	CbGpPWpGaD
Nifedipine—CALM3—Innate Immune System—JUN—psoriasis	8.73e-06	0.000122	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	8.65e-06	0.000121	CbGpPWpGaD
Nifedipine—CALM2—Immune System—HLA-A—psoriasis	8.53e-06	0.000119	CbGpPWpGaD
Nifedipine—CALM1—Immune System—HLA-A—psoriasis	8.53e-06	0.000119	CbGpPWpGaD
Nifedipine—CALM3—Hemostasis—VEGFA—psoriasis	8.48e-06	0.000118	CbGpPWpGaD
Nifedipine—CALM2—Innate Immune System—JUN—psoriasis	8.45e-06	0.000118	CbGpPWpGaD
Nifedipine—CALM1—Innate Immune System—JUN—psoriasis	8.45e-06	0.000118	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—CAT—psoriasis	8.42e-06	0.000117	CbGpPWpGaD
Nifedipine—CALM3—Immune System—CRP—psoriasis	8.41e-06	0.000117	CbGpPWpGaD
Nifedipine—CALM3—Innate Immune System—NFKB1—psoriasis	8.41e-06	0.000117	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—CAT—psoriasis	8.25e-06	0.000115	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—CAT—psoriasis	8.23e-06	0.000115	CbGpPWpGaD
Nifedipine—CALM2—Hemostasis—VEGFA—psoriasis	8.2e-06	0.000114	CbGpPWpGaD
Nifedipine—CALM1—Hemostasis—VEGFA—psoriasis	8.2e-06	0.000114	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—CAT—psoriasis	8.19e-06	0.000114	CbGpPWpGaD
Nifedipine—CALM3—Disease—HLA-A—psoriasis	8.14e-06	0.000113	CbGpPWpGaD
Nifedipine—CALM2—Immune System—CRP—psoriasis	8.14e-06	0.000113	CbGpPWpGaD
Nifedipine—CALM1—Immune System—CRP—psoriasis	8.14e-06	0.000113	CbGpPWpGaD
Nifedipine—CALM2—Innate Immune System—NFKB1—psoriasis	8.13e-06	0.000113	CbGpPWpGaD
Nifedipine—CALM1—Innate Immune System—NFKB1—psoriasis	8.13e-06	0.000113	CbGpPWpGaD
Nifedipine—CYP2A6—Metabolism—APOE—psoriasis	8.11e-06	0.000113	CbGpPWpGaD
Nifedipine—CALM3—Adaptive Immune System—NFKB1—psoriasis	8.07e-06	0.000113	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—CARM1—psoriasis	8.06e-06	0.000112	CbGpPWpGaD
Nifedipine—CALM3—Immune System—HLA-DRB1—psoriasis	8.06e-06	0.000112	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—CAT—psoriasis	7.93e-06	0.00011	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—CAT—psoriasis	7.93e-06	0.00011	CbGpPWpGaD
Nifedipine—CALM2—Disease—HLA-A—psoriasis	7.88e-06	0.00011	CbGpPWpGaD
Nifedipine—CALM1—Disease—HLA-A—psoriasis	7.88e-06	0.00011	CbGpPWpGaD
Nifedipine—CALM2—Adaptive Immune System—NFKB1—psoriasis	7.81e-06	0.000109	CbGpPWpGaD
Nifedipine—CALM1—Adaptive Immune System—NFKB1—psoriasis	7.81e-06	0.000109	CbGpPWpGaD
Nifedipine—CALM2—Immune System—HLA-DRB1—psoriasis	7.8e-06	0.000109	CbGpPWpGaD
Nifedipine—CALM1—Immune System—HLA-DRB1—psoriasis	7.8e-06	0.000109	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—CAT—psoriasis	7.78e-06	0.000108	CbGpPWpGaD
Nifedipine—CALM3—Immune System—ICAM1—psoriasis	7.73e-06	0.000108	CbGpPWpGaD
Nifedipine—CYP3A7—Metabolism—PPARG—psoriasis	7.71e-06	0.000107	CbGpPWpGaD
Nifedipine—CALM3—Immune System—NFKBIA—psoriasis	7.67e-06	0.000107	CbGpPWpGaD
Nifedipine—CALM3—Disease—APOE—psoriasis	7.6e-06	0.000106	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	7.53e-06	0.000105	CbGpPWpGaD
Nifedipine—CALM2—Immune System—ICAM1—psoriasis	7.48e-06	0.000104	CbGpPWpGaD
Nifedipine—CALM1—Immune System—ICAM1—psoriasis	7.48e-06	0.000104	CbGpPWpGaD
Nifedipine—CALM2—Immune System—NFKBIA—psoriasis	7.42e-06	0.000103	CbGpPWpGaD
Nifedipine—CALM1—Immune System—NFKBIA—psoriasis	7.42e-06	0.000103	CbGpPWpGaD
Nifedipine—CALM1—Disease—APOE—psoriasis	7.35e-06	0.000102	CbGpPWpGaD
Nifedipine—CALM2—Disease—APOE—psoriasis	7.35e-06	0.000102	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—SOCS1—psoriasis	7.21e-06	0.000101	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—CAT—psoriasis	7.13e-06	9.93e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—NOS2—psoriasis	7.08e-06	9.87e-05	CbGpPWpGaD
Nifedipine—CYP2A6—Metabolism—PPARG—psoriasis	7.06e-06	9.84e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—SOCS1—psoriasis	6.98e-06	9.73e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—SOCS1—psoriasis	6.98e-06	9.73e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—TYK2—psoriasis	6.88e-06	9.59e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—NOS2—psoriasis	6.85e-06	9.55e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—NOS2—psoriasis	6.85e-06	9.55e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—TYK2—psoriasis	6.65e-06	9.27e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—TYK2—psoriasis	6.65e-06	9.27e-05	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—APOE—psoriasis	6.54e-06	9.12e-05	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—APOE—psoriasis	6.41e-06	8.93e-05	CbGpPWpGaD
Nifedipine—CALM3—Hemostasis—TP53—psoriasis	6.4e-06	8.93e-05	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—APOE—psoriasis	6.39e-06	8.91e-05	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—APOE—psoriasis	6.37e-06	8.87e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—TYK2—psoriasis	6.28e-06	8.76e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—CARM1—psoriasis	6.22e-06	8.67e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—CAT—psoriasis	6.21e-06	8.65e-05	CbGpPWpGaD
Nifedipine—CALM1—Hemostasis—TP53—psoriasis	6.2e-06	8.63e-05	CbGpPWpGaD
Nifedipine—CALM2—Hemostasis—TP53—psoriasis	6.2e-06	8.63e-05	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—APOE—psoriasis	6.16e-06	8.58e-05	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—APOE—psoriasis	6.16e-06	8.58e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—TYK2—psoriasis	6.08e-06	8.47e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—TYK2—psoriasis	6.08e-06	8.47e-05	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—APOE—psoriasis	6.04e-06	8.42e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—CXCL8—psoriasis	5.99e-06	8.35e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—IFNG—psoriasis	5.89e-06	8.2e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—CAT—psoriasis	5.85e-06	8.16e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—TYK2—psoriasis	5.8e-06	8.09e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—CAT—psoriasis	5.8e-06	8.09e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—CXCL8—psoriasis	5.79e-06	8.07e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—CXCL8—psoriasis	5.79e-06	8.07e-05	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—PPARG—psoriasis	5.7e-06	7.94e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—IFNG—psoriasis	5.69e-06	7.93e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—IFNG—psoriasis	5.69e-06	7.93e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—CD4—psoriasis	5.68e-06	7.92e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—TYK2—psoriasis	5.61e-06	7.82e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—TYK2—psoriasis	5.61e-06	7.82e-05	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—PPARG—psoriasis	5.58e-06	7.78e-05	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—PPARG—psoriasis	5.57e-06	7.76e-05	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—PPARG—psoriasis	5.55e-06	7.73e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—APOE—psoriasis	5.54e-06	7.72e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—CD4—psoriasis	5.5e-06	7.66e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—CD4—psoriasis	5.5e-06	7.66e-05	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—PPARG—psoriasis	5.36e-06	7.48e-05	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—PPARG—psoriasis	5.36e-06	7.48e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—LEP—psoriasis	5.32e-06	7.42e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—APOE—psoriasis	5.32e-06	7.42e-05	CbGpPWpGaD
Nifedipine—CALM3—Innate Immune System—IL6—psoriasis	5.28e-06	7.36e-05	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—PPARG—psoriasis	5.26e-06	7.33e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—CD4—psoriasis	5.25e-06	7.31e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—APOE—psoriasis	5.15e-06	7.18e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—LEP—psoriasis	5.15e-06	7.18e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—APOE—psoriasis	5.15e-06	7.18e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—LEP—psoriasis	5.15e-06	7.18e-05	CbGpPWpGaD
Nifedipine—CALM1—Innate Immune System—IL6—psoriasis	5.11e-06	7.11e-05	CbGpPWpGaD
Nifedipine—CALM2—Innate Immune System—IL6—psoriasis	5.11e-06	7.11e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—JUN—psoriasis	5.09e-06	7.09e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—CD4—psoriasis	5.08e-06	7.07e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—CD4—psoriasis	5.08e-06	7.07e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—NFKBIA—psoriasis	4.96e-06	6.91e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—CAT—psoriasis	4.96e-06	6.91e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—JUN—psoriasis	4.92e-06	6.86e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—JUN—psoriasis	4.92e-06	6.86e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—NFKB1—psoriasis	4.9e-06	6.82e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—APOE—psoriasis	4.83e-06	6.72e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—PPARG—psoriasis	4.82e-06	6.72e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—NFKBIA—psoriasis	4.8e-06	6.69e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—NFKBIA—psoriasis	4.8e-06	6.69e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—NFKB1—psoriasis	4.74e-06	6.6e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—NFKB1—psoriasis	4.74e-06	6.6e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—APOE—psoriasis	4.55e-06	6.34e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—APOE—psoriasis	4.51e-06	6.28e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—STAT3—psoriasis	4.4e-06	6.13e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—STAT3—psoriasis	4.26e-06	5.93e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—STAT3—psoriasis	4.26e-06	5.93e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PPARG—psoriasis	4.2e-06	5.86e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—TYK2—psoriasis	4.06e-06	5.66e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—STAT3—psoriasis	4.06e-06	5.66e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PPARG—psoriasis	3.96e-06	5.52e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—TYK2—psoriasis	3.93e-06	5.48e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—TYK2—psoriasis	3.93e-06	5.48e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—STAT3—psoriasis	3.93e-06	5.48e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—STAT3—psoriasis	3.93e-06	5.48e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PPARG—psoriasis	3.93e-06	5.47e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—APOE—psoriasis	3.85e-06	5.37e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—CAT—psoriasis	3.83e-06	5.33e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CXCL8—psoriasis	3.54e-06	4.93e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CXCL8—psoriasis	3.42e-06	4.77e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CXCL8—psoriasis	3.42e-06	4.77e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—IL6—psoriasis	3.36e-06	4.69e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PPARG—psoriasis	3.36e-06	4.68e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—JUN—psoriasis	3.29e-06	4.58e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—IL6—psoriasis	3.25e-06	4.54e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—IL6—psoriasis	3.25e-06	4.54e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—JUN—psoriasis	3.18e-06	4.43e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—JUN—psoriasis	3.18e-06	4.43e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—NFKB1—psoriasis	3.17e-06	4.41e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—IL6—psoriasis	3.07e-06	4.28e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—NFKB1—psoriasis	3.06e-06	4.27e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—NFKB1—psoriasis	3.06e-06	4.27e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—IL6—psoriasis	2.97e-06	4.14e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—IL6—psoriasis	2.97e-06	4.14e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—APOE—psoriasis	2.97e-06	4.14e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—VEGFA—psoriasis	2.87e-06	4e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—STAT3—psoriasis	2.85e-06	3.97e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—IL6—psoriasis	2.84e-06	3.96e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—VEGFA—psoriasis	2.78e-06	3.87e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—VEGFA—psoriasis	2.78e-06	3.87e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—STAT3—psoriasis	2.75e-06	3.84e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—STAT3—psoriasis	2.75e-06	3.84e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—IL6—psoriasis	2.75e-06	3.83e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—IL6—psoriasis	2.75e-06	3.83e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PPARG—psoriasis	2.59e-06	3.61e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—TP53—psoriasis	2.17e-06	3.03e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—TP53—psoriasis	2.1e-06	2.93e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—TP53—psoriasis	2.1e-06	2.93e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—IL6—psoriasis	1.99e-06	2.77e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—IL6—psoriasis	1.92e-06	2.68e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—IL6—psoriasis	1.92e-06	2.68e-05	CbGpPWpGaD
